|
Volumn 144, Issue 2, 2013, Pages
|
Portal vein thrombosis in cirrhosis: Ignore, prevent, or treat?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
LOW MOLECULAR WEIGHT HEPARIN;
ANTICOAGULANT AGENT;
BACTERIAL DNA;
ENOXAPARIN;
ANTICOAGULATION;
DECOMPENSATED LIVER CIRRHOSIS;
ECHOGRAPHY;
FOLLOW UP;
HUMAN;
INCIDENCE;
LETTER;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
MORBIDITY;
MORTALITY;
OUTPATIENT DEPARTMENT;
PORTAL VEIN BLOOD FLOW;
PORTAL VEIN THROMBOSIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RECANALIZATION;
SCREENING TEST;
THROMBOSIS PREVENTION;
VARICOSIS;
BLEEDING;
RISK FACTOR;
BLOOD;
FEMALE;
KIDNEY VEIN;
LIVER FAILURE;
MALE;
NOTE;
THROMBOSIS;
ANTICOAGULANTS;
DNA, BACTERIAL;
ENOXAPARIN;
FEMALE;
HUMANS;
LIVER CIRRHOSIS;
LIVER FAILURE;
MALE;
RENAL VEINS;
THROMBOSIS;
|
EID: 84881485234
PISSN: 00165085
EISSN: 15280012
Source Type: Journal
DOI: 10.1053/j.gastro.2012.11.036 Document Type: Letter |
Times cited : (9)
|
References (7)
|